Your browser doesn't support javascript.
loading
Cerebrovascular Events in Older Patients With Patent Foramen Ovale: Current Status and Future Perspectives / 대한뇌졸중학회지
Journal of Stroke ; : 338-349, 2023.
Article em En | WPRIM | ID: wpr-1001589
Biblioteca responsável: WPRO
ABSTRACT
Patent foramen ovale (PFO) closure, along with medical therapy, has emerged as the therapeutic gold standard in younger (60 years) patients with a PFO-related cerebrovascular event, a complex group of patients who were mostly excluded from PFO closure clinical trials. Nevertheless, several studies have shown a higher prevalence of PFO among older patients with cryptogenic stroke, and its presence has been associated with an increased risk of recurrent events. Furthermore, older patients exhibit a higher prevalence of high-risk PFO anatomical features, present inherent age-related risk factors that might increase the risk of paradoxical embolism through a PFO, and have a higher incidence of ischemic events after a PFO-related event. Additionally, observational studies have shown the safety and preliminary efficacy of PFO closure in older PFO-related stroke patients. Yet, higher rates of recurrent cerebrovascular events and new-onset atrial fibrillation were observed in some studies among older patients compared to their younger counterparts. After careful case-by-case evaluation, including the assessment of hidden potential cardioembolic sources of a cryptogenic stroke other than PFO, transcatheter PFO closure might be a safe and effective therapeutic option for preventing recurrent thromboembolic events in patients >60 years with a high-risk PFO-associated stroke. Ongoing trials will provide important insights into the role of PFO closure in the elderly population.
Texto completo: 1 Base de dados: WPRIM Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo: 1 Base de dados: WPRIM Idioma: En Ano de publicação: 2023 Tipo de documento: Article